News 最新消息

Interested in SAMe?
Dr. David Mischoulon will give us a state of the art talk on where we are with SAMe


Dr. David Mischoulon had been invited to Mind-Body Interface Int'l Symposium in 2011 and 2015 (Natural Remedies for Mental Health). His talks received wonderful feedbacks and inspired many clinicians and researchers. This year, David will share new results of his SAMe study and present a systematic review of this agent. You can't miss it.




David Mischoulon, MD, PhD

S-Adenosyl-L-Methionine (SAMe) for Neuropsychiatric Disorders: Latest Clinical and Mechanistic Evidence


  • Director, Depression Clinical and Research Program, Massachusetts General Hospital, MA, USA
  • Associate Professor of Psychiatry, Harvard Medical School, Boston, MA, USA







Posted on 2017-03-25Share this: